Literature DB >> 22798441

Paraneoplastic ataxia and dystonia secondary to a malignant fibrous histiocytoma.

Ross Dolan1, Ralph Thomas, Jonathan I O'Riordan.   

Abstract

Paraneoplastic movement disorders are part of the spectrum of paraneoplastic syndromes caused by the production of onconeural antibodies such as anti-Hu by underlying tumours. These attack specific neurons depending on receptor aetiology. We report the case of a 53-year-old man who presented 8 years previously with symptoms of upper limb weakness, light headedness, dizziness and falls. His condition followed a progressive course. Two years after onset he had right-sided weakness, diplopia and generalised dystonia. Initial investigations identified a positive anti-Hu antibody, but an extensive search for a primary tumour was negative. A malignant fibrous histiocytoma in his right gluteal fold was subsequently identified. At this stage he was bed bound with severe ataxia, dystonia and spasticity. Following surgical excision and treatment with high dose steroids and pulse immunoglobulin, further progression was arrested and minor improvements occurred. He can now ambulate with bilateral assistance but remains severely disabled.

Entities:  

Mesh:

Year:  2010        PMID: 22798441      PMCID: PMC3029154          DOI: 10.1136/bcr.05.2010.2983

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Paraneoplastic brainstem encephalitis in a patient with malignant fibrous histiocytoma and atypical anti-neuronal antibodies.

Authors:  Manuel Corato; Kalliope Marinou-Aktipi; Rosanna Nano; Bruno Giometto; Cristina Cereda; Guido Natoli; Angelica Facoetti; Mauro Ceroni
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 2.  [Paraneoplastic disorders of the nervous system].

Authors:  Josep Dalmau
Journal:  Rinsho Shinkeigaku       Date:  2008-11

Review 3.  Paraneoplastic movement disorders.

Authors:  Robin Grant; Francesc Graus
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

4.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

5.  Paraneoplastic paralysis in a patient with malignant fibrous histiocytoma.

Authors:  L Reinecke; A L Thornley
Journal:  Br J Clin Pract       Date:  1992

Review 6.  Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease.

Authors:  J Hammack; H Kotanides; M K Rosenblum; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

7.  Paraneoplastic opsoclonus-myoclonus syndrome associated with malignant fibrous histiocytoma: neuropathological findings.

Authors:  J Zámecník; R Cerný; A Bartos; J Jerábek; M Bojar
Journal:  Cesk Patol       Date:  2004-04

8.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

Review 9.  Paraneoplastic neurological syndromes.

Authors:  Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Orphanet J Rare Dis       Date:  2007-05-04       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.